Efficacy and Safety of rhGH (Jintropin®) in Pediatric Participants With ISS

NCT03635580 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

480

Enrollment

INDUSTRY

Sponsor class

Conditions

Dwarfism

Interventions

OTHER: Negative control

Sponsor

Changchun GeneScience Pharmaceutical Co., Ltd.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]